Abstract B103: Integrative genomic and proteomic analyses identify novel targets for Lkb1 deficient metastatic lung tumors
Year: 2009
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Julian Carretero, Takeshi Shimamura, Klarisa Rikova, Ting-Lei Gu, Christa L. Borgman, S. Buttarazzi, Kate L. McNamara, Kathleyn A. Brandstetter, Jeffrey C. Silva, Geoffrey I. Shapiro, Diego H. Castrillon, Michel Maira, Carlos García-Echeverría, Carla F. Kim, Nabeel Bardeesy, Norman E. Sharpless, William Y. Kim, Jeffrey A. Engelman, Kwok K. Wong
Institutions: Dana-Farber Cancer Institute, Cell Signaling Technology (United States), The University of Texas Southwestern Medical Center, Novartis (Switzerland), Novartis Institutes for BioMedical Research, Boston Children's Hospital, Massachusetts General Hospital, University of North Carolina at Chapel Hill
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2080580465